These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21645664)

  • 1. Review of the applications of different analytical techniques for coxibs research.
    Starek M
    Talanta; 2011 Jul; 85(1):8-27. PubMed ID: 21645664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of the recent developments in analytical methodologies for determination of COX-2 inhibitors in bulk drugs, pharmaceuticals and biological matrices.
    Nageswara Rao R; Meena S; Raghuram Rao A
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):349-63. PubMed ID: 16009523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of bisphosphonate active pharmaceutical ingredients in pharmaceuticals and biological material: a review of analytical methods.
    Zacharis CK; Tzanavaras PD
    J Pharm Biomed Anal; 2008 Nov; 48(3):483-96. PubMed ID: 18599247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of recent applications of flow injection spectrophotometry to pharmaceutical analysis.
    Tzanavaras PD; Themelis DG
    Anal Chim Acta; 2007 Apr; 588(1):1-9. PubMed ID: 17386786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipophilicity study of some non-steroidal anti-inflammatory agents and cephalosporin antibiotics: a review.
    Dąbrowska M; Starek M; Skuciński J
    Talanta; 2011 Oct; 86():35-51. PubMed ID: 22063509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk.
    Solomon DH; Avorn J; Stürmer T; Glynn RJ; Mogun H; Schneeweiss S
    Arthritis Rheum; 2006 May; 54(5):1378-89. PubMed ID: 16645966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs.
    Hermann M; Ruschitzka F
    Ann Med; 2007; 39(1):18-27. PubMed ID: 17364448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is there a future for COX-2 inhibitors?].
    Yodfat Y
    Harefuah; 2004 Nov; 143(11):820-4, 837. PubMed ID: 15603272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of non-steroidal anti-inflammatory drug (NSAIDs) residues in water samples.
    Kosjek T; Heath E; Krbavcic A
    Environ Int; 2005 Jul; 31(5):679-85. PubMed ID: 15910964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chiral separation of agricultural fungicides.
    Pérez-Fernández V; García MÁ; Marina ML
    J Chromatogr A; 2011 Sep; 1218(38):6561-82. PubMed ID: 21864842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coxibs, non-steroidal anti-inflammatory drugs and cardiovascular risk.
    Hermann M; Ruschitzka F
    Intern Med J; 2006 May; 36(5):308-19. PubMed ID: 16650196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceuticals and related drugs.
    Gilpin RK; Gilpin CS
    Anal Chem; 2007 Jun; 79(12):4275-93. PubMed ID: 17511425
    [No Abstract]   [Full Text] [Related]  

  • 13. A review of analytical techniques for determination of oxicams, nimesulide and nabumetone.
    Starek M; Krzek J
    Talanta; 2009 Jan; 77(3):925-42. PubMed ID: 19064072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rofecoxib: an update on physicochemical, pharmaceutical, pharmacodynamic and pharmacokinetic aspects.
    Ahuja N; Singh A; Singh B
    J Pharm Pharmacol; 2003 Jul; 55(7):859-94. PubMed ID: 12906745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular complications of non-steroidal anti-inflammatory drugs.
    Fosslien E
    Ann Clin Lab Sci; 2005; 35(4):347-85. PubMed ID: 16254252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioanalysis and Analytical Services Research Group at The Municipal Institute for Medical Research IMIM-Hospital del Mar, Spain.
    Segura J; Pascual JA; Ventura R; Gutiérrez-Gallego R
    Bioanalysis; 2009 Nov; 1(8):1403-9. PubMed ID: 21083089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COX-2-selective inhibitors (COXIBs): gastrointestinal safety.
    Pronai L; Hritz I; Molnar B; Herszenyi L; Tulassay Z
    Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):23-30. PubMed ID: 14552701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evidence-based approach to prescribing nonsteroidal antiinflammatory drugs. Third Canadian Consensus Conference.
    Tannenbaum H; Bombardier C; Davis P; Russell AS;
    J Rheumatol; 2006 Jan; 33(1):140-57. PubMed ID: 16331802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coxibs: Evolving role in pain management.
    Katz N
    Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):15-24. PubMed ID: 12528070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What happened to the prescribing of other COX-2 inhibitors, paracetamol and non-steroidal anti-inflammatory drugs when rofecoxib was withdrawn in Australia?
    Barozzi N; Tett SE
    Pharmacoepidemiol Drug Saf; 2007 Nov; 16(11):1184-91. PubMed ID: 17636557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.